Get started
Keyword

MDMA

Description: MDMA, or 3,4-methylenedioxymethamphetamine, is a psychoactive empathogen and stimulant studied in neuroscience, psychiatry, and drug research.
Wikidata ID: wiki/Q69488
OpenAlex ID: keywords/mdma
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
2001 · David L. Braff, Mark A. Geyer, et al. · Psychopharmacology · 1,707
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 · Antonio Verdejo-García, Andrew J. Lawrence, et al. · Neuroscience & Biobehavioral Reviews · 1,424
Non-destructive terahertz imaging of illicit drugs using spectral fingerprints
2003 · Kodo Kawase, Yuichi Ogawa, et al. · Optics Express · 1,376
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 · A. Richard Green, Annis O. Mechan, et al. · Pharmacological Reviews · 1,272
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
2021 · Jennifer M. Mitchell, Michael Bogenschutz, et al. · Nature Medicine · 995
PDF
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
2000 · Richard B. Rothman, Michael H. Baumann, et al. · Synapse · 939
New Insights into the Mechanism of Action of Amphetamines
2007 · Annette E. Fleckenstein, Trent J. Volz, et al. · The Annual Review of Pharmacology and Toxicology · 732
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
1992 · J.A. Henry, K.J. Jeffreys, et al. · The Lancet · 729
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
2010 · Erich Studerus, Alex Gamma, et al. · PLoS ONE · 682
PDF
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
2010 · Michael C Mithoefer, Mark T Wagner, et al. · Journal of Psychopharmacology · 673
Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings
1998 · UD McCann, Z Szabo, et al. · The Lancet · 660
Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor
2001 · James R. Bunzow, Mark S. Sonders, et al. · Molecular Pharmacology · 651
Psychedelics and Psychedelic-Assisted Psychotherapy
2020 · Collin M. Reiff, Elon E. Richman, et al. · American Journal of Psychiatry · 648
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
2001 · H Kalant · PubMed · 612
Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens
1986 · David E. Nichols · Journal of Psychoactive Drugs · 563
Deficits in behavioural inhibition in substance abuse and addiction: A meta-analysis
2014 · Janette L. Smith, Richard P. Mattick, et al. · Drug and Alcohol Dependence · 545
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity
1988 · E O'Hearn, G Battaglia, et al. · Journal of Neuroscience · 543
PDF
The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.
1992 · G Rudnick, S C Wall · Proceedings of the National Academy of Sciences · 535
Invited Review Free radicals and the pathobiology of brain dopamine systems
1998 · Jean Lud Cadet, Christie Brannock · Neurochemistry International · 499
Developmental Consequences of Fetal Exposure to Drugs: What We Know and What We Still Must Learn
2014 · Emily J Ross, Devon L Graham, et al. · Neuropsychopharmacology · 476
PDF
3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
1987 · G Battaglia, S Y Yeh, et al. · Journal of Pharmacology and Experimental Therapeutics · 458
Impaired spatial and sequential learning in rats treated neonatally with d ‐fenfluramine
2002 · L. L. Morford, S. L. Inman‐Wood, et al. · European Journal of Neuroscience · 455
Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
1987 · D L Commins, G Vosmer, et al. · Journal of Pharmacology and Experimental Therapeutics · 453
Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers
1998 · Franz X Vollenweider, Alex Gamma, et al. · Neuropsychopharmacology · 448
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
2023 · Jennifer M. Mitchell, Marcela Ot’alora G., et al. · Nature Medicine · 445
PDF
Works count: 12,180
Citation count: 262,700
Year
Topic
Type